HealthScienceTop Stories

CAGR 15.8% Growth Estimated in Neuroprosthetics Market by 2024 | A report by Boston Scientific Corporation, Biomet, Cyberonics, Cochlear, Medtronic and others

Neuroprosthetic market is a whole history evaluation of industry, which includes an assessment of the parental market. It is a professional and a particular report focusing on predominant and secondary drivers, market share, leading segments and geographical analysis. The Neuroprosthetic market document offers an in-depth overview of Product Specification, technology, product kind and production analysis thinking about essential elements such as Revenue, Cost, Gross and Gross Margin. Top players and brands are making moves such as developments, merchandise launches, acquisitions, merges, joint ventures and competitive research in the Neuroprosthetic market. Further, key players, principal collaborations, merger & acquisitions alongside with trending innovation and enterprise policies are reviewed in the report.

Market Analysis:

Neuroprosthetic devices are bio medically engineered devices to be linked to the peripheral or central nervous system to enhance the cognitive, motor or sensory abilities. Global Neuroprosthetics Market accounted for USD 7.78 billion in 2016 and will be growing at a CAGR of 15.8% during the forecast period of 2019 to 2024. This upcoming market reports contain data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2019 to 2024

Download Sample PDF Report

Major Competitors:

  • Global neuroprosthetics market is dominated by
  • Boston Scientific Corporation
  • Biomet
  • Cyberonics
  • Cochlear
  • Medtronic
  • NDI Medical
  • NeuroPace
  • Nevro Corp
  • Retina Implant AG
  • Jude Medical
  • Sonova
  • SensArs
  • CorTec GmbHamong others.


Major Market Drivers and Restraints: 

  • Increasing prevalence of neurological disorders
  • Rising geriatric population
  • Increasing awareness among people
  • Involvement of government support
  • Demand for cost-effective and technologically advanced implants
  • Issues related to reimbursementschemes
  • High cost of Neuroprostheticsdevices
  • High procedure cost



  • motor neuron disorders
  • physiological disorders
  • cognitive disorders

Motor neuron disorders is further sub segmented into

  • Parkinson’s disease
  • epilepsy

Physiological disorders are further sub-segmented into

  • auditory processing disorders
  • ophthalmic disorders
  • cardiovascular disorders
  • kidney diseases

Whereas cognitive disorders are sub-segmented into

  • Alzheimer’s disease
  • deveredepression

End user

  • hospitals
  • clinics


  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East
  • Africa

Major countries

  • US., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

Competitive Analysis:

The global neuroprosthetics market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global neuroprostheticsmarketfor global, Europe, North America, Asia Pacific, and South America.

Speak to Author


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *